Abstract:In vivo optical imaging of trace biomarkers in residual microtumors holds significant promise for cancer prognosis but poses a formidable challenge. Here, a novel hydrogel sensor is designed for ultrasensitive and specific imaging of the elusive biomarker. This hydrogel sensor seamlessly integrates a molecular beacon nanoprobe with fibroblasts, offering both high tissue retention capability and an impressive signal-to-noise ratio for imaging. Signal amplification is accomplished through exonuclease I-mediated biomarker recycling. The resulting hydrogel sensor sensitively detects the biomarker carcinoembryonic antigen with a detection limit of 1.8 pg mL-1 in test tubes. Moreover, it successfully identifies residual cancer nodules with a median diameter of less than 2 mm in mice bearing partially removed primary triple-negative breast carcinomas (4T1). Notably, this hydrogel sensor is proven effective for the sensitive diagnosis of invasive tumors in post-surgical mice with infiltrating 4T1 cells, leveraging the role of fibroblasts in locally enriching tumor cells. Furthermore, the residual microtumor is rapidly photothermal ablation by polydopamine-based nanoprobe under the guidance of visualization, achieving approximate to 100% suppression of tumor recurrence and lung metastasis. This work offers a promising alternative strategy for visually detecting residual microtumors, potentially enhancing the prognosis of cancer patients following surgical interventions. A postoperative implantable hydrogel sensor integrating a molecular beacon (MB) nanoprobe and fibroblasts is designed for visual detection and elimination of residual microtumors by ultrasensitive in situ monitoring of trace biomarkers, whose amplification of the signal is achieved by fibroblast-mediated local enrichment of tumor cells and spatially selective release of exonuclease I (exo I)-triggered biomarker recycling.image

A Microfluidic Approach for Anticancer Drug Analysis Based on Hydrogel Encapsulated Tumor Cells.

Recent Advances in Microfluidic Technology and Applications for Anti-Cancer Drug Screening

A Novel Micro-Groove Impedance Sensor for 3D Cell Viability Monitoring and High-Throughput Drug Screening

3D Microgroove Electrical Impedance Sensing to Examine 3D Cell Cultures for Antineoplastic Drug Assessment

3D Cell-Based Biosensor for Cell Viability and Drug Assessment by 3D Electric Cell/matrigel-Substrate Impedance Sensing.

Lab-on-a-Chip for Anticancer Drug Screening Using Quantum Dots Probe Based Apoptosis Assay.

Ultrasensitive Optical Detection and Elimination of Residual Microtumors with a Postoperative Implantable Hydrogel Sensor for Preventing Cancer Recurrence.

Pancreatic Cancer Cell Line in Responsive Hydrogel Microcapsules for Drug Evaluation

Primary Human Pancreatic Cancer Cells Cultivation in Microfluidic Hydrogel Microcapsules for Drug Evaluation

Analysis of nonadherent apoptotic cells by a quantum dots probe in a microfluidic device for drug screening.

Integrated Microfluidic Platform with Multiple Functions To Probe Tumor-Endothelial Cell Interaction.

Microfluidic adhesion analysis of single glioma cells for evaluating the effect of drugs

Drug screening of cancer cell lines and human primary tumors using droplet microfluidics

Microfluidic chip for non-invasive analysis of tumor cells interaction with anti-cancer drug doxorubicin by AFM and Raman spectroscopy

A UV-sensitive Hydrogel Based Combinatory Drug Delivery Chip (UV Gel-Drug Chip) for Cancer Cocktail Drug Screening

Targeted isolation and analysis of single tumor cells with aptamer-encoded microwell array on microfluidic device.

Droplet Microfluidics for Tumor Drug‐Related Studies and Programmable Artificial Cells

Biomacromolecular hydrogel scaffolds from microfluidics for cancer therapy: A review

Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.

Antibody-free Isolation and Regulation of Adherent Cancer Cells Via Hybrid Branched Microtube-Sandwiched Hydrodynamic System

A Perfused Two-Chamber System For Anticancer Drug Screening